CSI Market
Sign In | Register

Cvs Health (CVS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CVS quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Cvs Health manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income1,728.00
Depreciation & amortization4,606.00
Amortization of Other Assets0.00
Interest expense0.00
Goodwill, Impairment Loss5,725.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1,267.00
Share-based plans0.00
Gain (Loss) on Disposition of Business236.00
Share-based Compensation535.00
Minority interest0.00
Gains (Losses) on Extinguishment of Debt0.00
Gain On Sale Of Subsidiary-
Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies-216,493.00
Payments for Inventory and Prescriptions Dispensedby Retail Network Pharmacies-
Payments for Insurance Benefits-
Deconsolidation Gain Or Loss Amount-483.00
Deferred Income Taxes And Other Items-
Income taxes102.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts Receivable-3,498.00
Increase (Decrease) in Accounts Payable3,855.00
Increase (Decrease) in Accrued Liabilities0.00
Advances in excess of costs0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital-564.00
Other Noncash Income (Expense)-336.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities216,493.00
Discontinued operations0.00
Net Cash flow from Operating Activities10,639.00
Investing Activities
Capital Expenditures-2,832.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities12,383.00
Payments to Acquire Available-for-sale Securities0.00
Proceeds from other investments0.00
Sale Leaseback Transaction Net Proceeds-
Proceeds from Sale of Property Plant and Equipment and Other Assets-
Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity-
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments to Acquire Investments-15,012.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-436.00
Payments to Acquire Additional Interest in Subsidiaries0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities26.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-5,871.00
Financing Activities
Short-term debt Net-2,119.00
Other borrowing transactions0.00
Long-term debt - borrowings3,969.00
Long-term debt - repayments-3,629.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock394.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-158.00
Purchase Of Noncontrolling Interest In Subsidiary-
Business Acquisition Contingent Consideration Arrangement Payment Madeto Seller for Tax Savingson Net Operating Loss Assumed-
Dividends paid to minority interests0.00
Dividends paid-3,397.00
Net Cash Flow from Financing Activities-4,940.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow7,807.00
Total Cash Flow-172.00
4 historic quarters locked

Sign in to unlock the full Cvs Health cash flow history.

Sign In Create Free Account

About Cvs Health Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 10, 2026
  • Source: cvs-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000064803-26-000010

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License